These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181 [TBL] [Abstract][Full Text] [Related]
3. [Use of mycophenolate mofetil in kidney transplantation]. Hrvacevic R; Ignjatovic Lj; Vavic N Vojnosanit Pregl; 2001; 58(4):415-9. PubMed ID: 11712223 [TBL] [Abstract][Full Text] [Related]
4. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation. Behrend M Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667 [TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group. Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174 [TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil in renal transplantation: results from the U.S. randomized trials. Danovitch GM Kidney Int Suppl; 1995 Dec; 52():S93-6. PubMed ID: 8587293 [TBL] [Abstract][Full Text] [Related]
8. Rescue therapy with mycophenolate mofetil. The Mycophenolate Mofetil Renal Refractory Rejection Study Group. Clin Transplant; 1996 Feb; 10(1 Pt 2):131-5. PubMed ID: 8680050 [TBL] [Abstract][Full Text] [Related]
9. The use of Mycophenolate Mofetil (Cellcept) in renal transplantation. Vanrenterghem Y Nephron; 1997; 76(4):392-9. PubMed ID: 9274835 [TBL] [Abstract][Full Text] [Related]
10. Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patients. Vasquez EM; Sifontis NM; Pollak R; Benedetti E Clin Transplant; 2001 Aug; 15(4):253-7. PubMed ID: 11683819 [TBL] [Abstract][Full Text] [Related]
15. Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection. Simmons WD; Rayhill SC; Sollinger HW Drug Saf; 1997 Aug; 17(2):75-92. PubMed ID: 9285199 [TBL] [Abstract][Full Text] [Related]
16. Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy. Ołdakowska-Jedynak U; Paczek L; Mucha K; Foroncewicz B; Perkowska-Ptasińska A Transplant Proc; 2006; 38(1):66-8. PubMed ID: 16504666 [TBL] [Abstract][Full Text] [Related]
17. [Use of mycophenolate mofetil (MMF) in kidney transplantation: results of a single center trial]. Pastural M; Barrou B; Golmard JL; Gorichon-Radideau E; Manighetti J; Ourahma S; Benalia H; Mouquet C; Chatelain C; Bitker MO Prog Urol; 1999 Feb; 9(1):19-25. PubMed ID: 10212949 [TBL] [Abstract][Full Text] [Related]
18. The use of mycophenolate mofetil in transplant recipients. Mele TS; Halloran PF Immunopharmacology; 2000 May; 47(2-3):215-45. PubMed ID: 10878291 [TBL] [Abstract][Full Text] [Related]
19. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment. Hutchinson P; Jose M; Atkins RC; Holdsworth SR Transpl Immunol; 2004; 13(1):55-61. PubMed ID: 15203129 [TBL] [Abstract][Full Text] [Related]
20. Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates. Nakamura K; Oshima S; Maeda M; Morio H; Fukahori H; Nakanishi T; Tsujimoto S; Hirose J; Noto T; Hamakawa N; Inami M; Morokata T Int Immunopharmacol; 2018 Nov; 64():201-207. PubMed ID: 30195818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]